A Multicentre, Randomised, Double Blind, Double Dummy, Active Comparator Controlled, Parallel Group Study of COLAL-PRED [prednisolone-metasulfobenzoate-sodium] in the Treatment of Moderate Acute Ulcerative Colitis
Phase of Trial: Phase III
Latest Information Update: 13 Apr 2017
At a glance
- Drugs Prednisolone metasulfobenzoate sodium (Primary) ; Prednisolone
- Indications Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Alizyme
- 10 Jun 2017 Biomarkers information updated
- 02 Nov 2012 Planned number of patients changed from 796 to 890.
- 25 Sep 2009 New trial record.